Molecular Techniques and Gene Mutations in Myelodysplastic Syndromes

被引：2
|
作者：
Mendoza, Hadrian [1 ]
Siddon, Alexa J. [2 ,3 ,4 ]
机构：
[1] Yale Sch Med, Dept Internal Med, POB 208030, New Haven, CT 06520 USA
[2] Yale Sch Med, Dept Lab Med, New Haven, CT USA
[3] Yale Sch Med, Dept Pathol, New Haven, CT USA
[4] Yale Sch Med, Dept Lab Med, 330 Cedar St,POB 208035, New Haven, CT 06520 USA
来源：
CLINICS IN LABORATORY MEDICINE | 2023年 / 43卷 / 04期
关键词：
Mutations; Myelodysplastic syndromes; Myelodysplasia; Next-generation sequencing; Whole-genome sequencing; ACUTE MYELOID-LEUKEMIA; BIOLOGICAL IMPLICATIONS; COHESIN COMPLEX; WHOLE GENOME; RISK; CLASSIFICATION; POPULATION; LANDSCAPE; EVOLUTION; VARIANTS;
D O I：
10.1016/j.cll.2023.06.002
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
[No abstract available]
引用
收藏
页码：549 / 563
页数：15
相关论文
共 50 条
  • [1] The molecular basis and clinical significance of genetic mutations identified in myelodysplastic syndromes
    Zhang, Ling
    Padron, Eric
    Lancet, Jeffrey
    LEUKEMIA RESEARCH, 2015, 39 (01) : 6 - 17
  • [2] Clinical and biological implications of driver mutations in myelodysplastic syndromes
    Papaemmanuil, Elli
    Gerstung, Moritz
    Malcovati, Luca
    Tauro, Sudhir
    Gundem, Gunes
    Van Loo, Peter
    Yoon, Chris J.
    Ellis, Peter
    Wedge, David C.
    Pellagatti, Andrea
    Shlien, Adam
    Groves, Michael John
    Forbes, Simon A.
    Raine, Keiran
    Hinton, Jon
    Mudie, Laura J.
    McLaren, Stuart
    Hardy, Claire
    Latimer, Calli
    Della Porta, Matteo G.
    O'Meara, Sarah
    Ambaglio, Ilaria
    Galli, Anna
    Butler, Adam P.
    Walldin, Gunilla
    Teague, Jon W.
    Quek, Lynn
    Sternberg, Alex
    Gambacorti-Passerini, Carlo
    Cross, Nicholas C. P.
    Green, Anthony R.
    Boultwood, Jacqueline
    Vyas, Paresh
    Hellstrom-Lindberg, Eva
    Bowen, David
    Cazzola, Mario
    Stratton, Michael R.
    Campbell, Peter J.
    BLOOD, 2013, 122 (22) : 3616 - 3627
  • [3] The molecular pathogenesis of the myelodysplastic syndromes
    Pellagatti, Andrea
    Boultwood, Jacqueline
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2015, 95 (01) : 3 - 15
  • [4] Mutations in epigenetic regulators in myelodysplastic syndromes
    Nikoloski, Gorica
    van der Reijden, Bert A.
    Jansen, Joop H.
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2012, 95 (01) : 8 - 16
  • [5] Combining gene variants with clinical characteristics improves outcome prediction in Chinese patients with myelodysplastic syndromes
    Yu, Yan
    Zhang, Tongtong
    Bao, Xiebing
    Wang, Qinrong
    Zhang, Ling
    Hong, Yang
    Zeng, Zhao
    Shen, Hongjie
    Wu, Depei
    Pan, Jinlan
    Liu, Hong
    Chen, Suning
    Sun, Aining
    LEUKEMIA & LYMPHOMA, 2020, 61 (04) : 919 - 926
  • [6] Molecular genetics in myelodysplastic syndromes
    Haferlach, Torsten
    LEUKEMIA RESEARCH, 2012, 36 (12) : 1459 - 1462
  • [7] Mutations in myelodysplastic syndromes: Core abnormalities and CHIPping away at the edges
    Caponetti, Gabriel C.
    Bagg, Adam
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2020, 42 (06) : 671 - 684
  • [8] NPM1 GENE MUTATIONS IN CHILDREN WITH MYELODYSPLASTIC SYNDROMES
    Jekic, Biljana
    Bunjevacki, Vera
    Dobricic, Valerija
    Novakovic, Ivana
    Milasin, Jelena
    Popovic, Branka
    Damnjanovic, Tatjana
    Maksimovic, Nela
    Perovic, V.
    Lukovic, Ljiljana
    ARCHIVES OF BIOLOGICAL SCIENCES, 2011, 63 (03) : 649 - 653
  • [9] Somatic mutations and epigenetic abnormalities in myelodysplastic syndromes
    Itzykson, Raphael
    Kosmider, Olivier
    Fenaux, Pierre
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2013, 26 (04) : 355 - 364
  • [10] Have we reached a molecular era in myelodysplastic syndromes?
    Voso, Maria Teresa
    Gurnari, Carmelo
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2021, (01) : 418 - 427
12345